Moons LMG - Search Results

1

The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study.

Backes Y, Elias SG, Bhoelan BS, Groen JN, van Bergeijk J, Seerden TCJ, Pullens HJM, Spanier BWM, Geesing JMJ, Kessels K, Kerkhof M, Siersema PD, de Vos Tot Nederveen Cappel WH, van Lelyveld N, Wolfhagen FHJ, Ter Borg F, Offerhaus GJA, Lacle MM, Moons LMG; Dutch T1 CRC Working Group. Backes Y, et al. Among authors: moons lmg. BMC Med. 2017 Jul 14;15(1):129. doi: 10.1186/s12916-017-0892-7. BMC Med. 2017. PMID: 28705200 Free PMC article.

2

[Acute dysphagia: often there is a readily treatable cause].

Moons LM, Kuipers EJ, Siersema PD. Moons LM, et al. Ned Tijdschr Geneeskd. 2003 Sep 6;147(36):1713-7. Ned Tijdschr Geneeskd. 2003. PMID: 14520793 Dutch.

3

The homeodomain protein CDX2 is an early marker of Barrett's oesophagus.

Moons LM, Bax DA, Kuipers EJ, Van Dekken H, Haringsma J, Van Vliet AH, Siersema PD, Kusters JG. Moons LM, et al. J Clin Pathol. 2004 Oct;57(10):1063-8. doi: 10.1136/jcp.2003.015727. J Clin Pathol. 2004. PMID: 15452161 Free PMC article.

4

Barrett's oesophagus is characterized by a predominantly humoral inflammatory response.

Moons LM, Kusters JG, Bultman E, Kuipers EJ, van Dekken H, Tra WM, Kleinjan A, Kwekkeboom J, van Vliet AH, Siersema PD. Moons LM, et al. J Pathol. 2005 Nov;207(3):269-76. doi: 10.1002/path.1847. J Pathol. 2005. PMID: 16177953

5

Does CDX2 expression predict Barrett's metaplasia in oesophageal columnar epithelium without goblet cells?

Kerkhof M, Bax DA, Moons LM, van Vuuren AJ, van Dekken H, Steyerberg EW, Kuipers EJ, Kusters JG, Siersema PD; Cybar Study Group. Kerkhof M, et al. Aliment Pharmacol Ther. 2006 Dec;24(11-12):1613-21. doi: 10.1111/j.1365-2036.2006.03163.x. Aliment Pharmacol Ther. 2006. PMID: 17206949

6

CDX2 expression in columnar metaplasia of the remnant esophagus in patients who underwent esophagectomy.

Bax D, Siersema PD, Moons LM, Dekken Hv, Tilanus HW, Kusters JG, Kuipers EJ. Bax D, et al. J Clin Gastroenterol. 2007 Apr;41(4):375-9. doi: 10.1097/01.mcg.0000225520.36160.52. J Clin Gastroenterol. 2007. PMID: 17413605

7

COX-2 CA-haplotype is a risk factor for the development of esophageal adenocarcinoma.

Moons LM, Kuipers EJ, Rygiel AM, Groothuismink AZ, Geldof H, Bode WA, Krishnadath KK, Bergman JJ, van Vliet AH, Siersema PD, Kusters JG. Moons LM, et al. Am J Gastroenterol. 2007 Nov;102(11):2373-9. doi: 10.1111/j.1572-0241.2007.01373.x. Epub 2007 Jun 20. Am J Gastroenterol. 2007. PMID: 17581270

8

Bile acid-stimulated expression of the farnesoid X receptor enhances the immune response in Barrett esophagus.

Capello A, Moons LM, Van de Winkel A, Siersema PD, van Dekken H, Kuipers EJ, Kusters JG. Capello A, et al. Am J Gastroenterol. 2008 Jun;103(6):1510-6. doi: 10.1111/j.1572-0241.2008.01908.x. Epub 2008 May 28. Am J Gastroenterol. 2008. PMID: 18510604

9

Expression, localization and polymorphisms of the nuclear receptor PXR in Barrett's esophagus and esophageal adenocarcinoma.

van de Winkel A, Menke V, Capello A, Moons LM, Pot RG, van Dekken H, Siersema PD, Kusters JG, van der Laan LJ, Kuipers EJ. van de Winkel A, et al. BMC Gastroenterol. 2011 Oct 6;11:108. doi: 10.1186/1471-230X-11-108. BMC Gastroenterol. 2011. PMID: 21977915 Free PMC article.

10

Functional single-nucleotide polymorphism of epidermal growth factor is associated with the development of Barrett's esophagus and esophageal adenocarcinoma.

Menke V, Pot RG, Moons LM, van Zoest KP, Hansen B, van Dekken H, Siersema PD, Kusters JG, Kuipers EJ. Menke V, et al. J Hum Genet. 2012 Jan;57(1):26-32. doi: 10.1038/jhg.2011.124. Epub 2011 Dec 1. J Hum Genet. 2012. PMID: 22129558

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

141 results

Search Page

Filters